developmental therapeuticsPhase I study of the pan-fibroblast growth factor receptor (FGFR) inhibitor BAY 1163877 with expansion cohorts for subjects based on tumor FGFR mRNA expression levels
Joerger, M., Soo, R., Cho, B.C., Mendivil, A. Navarro, Sayehli, C., Richly, H., Tai, D., Kim, D.-W., Wolf, J., Cassier, P., Ellinghaus, P., Hildebrandt, S., Behre, S., Helmbrecht, C., Kerpen, S., ZielVolume:
27
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdw435.10
Date:
October, 2016
File:
PDF, 42 KB
english, 2016